Mohammad Y Yakoob1, Peilin Shi1, Walter C Willett1, Kathryn M Rexrode1, Hannia Campos1, E John Orav1, Frank B Hu1, Dariush Mozaffarian2. 1. From Department of Epidemiology, Harvard School of Public Health, Boston, MA (M.Y.Y., D.M.); Friedman School of Nutrition Science & Policy, Tufts University, Boston, MA (P.S., D.M.); Department of Nutrition, Harvard School of Public Health, Boston, MA (W.C.W., H.C., F.B.H.); Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (K.M.R.); and Division of General Internal Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (E.J.O.). 2. From Department of Epidemiology, Harvard School of Public Health, Boston, MA (M.Y.Y., D.M.); Friedman School of Nutrition Science & Policy, Tufts University, Boston, MA (P.S., D.M.); Department of Nutrition, Harvard School of Public Health, Boston, MA (W.C.W., H.C., F.B.H.); Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (K.M.R.); and Division of General Internal Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (E.J.O.). dariush.mozaffarian@tufts.edu.
Abstract
BACKGROUND: In prospective studies, the relationship of self-reported consumption of dairy foods with risk of diabetes mellitus is inconsistent. Few studies have assessed dairy fat, using circulating biomarkers, and incident diabetes mellitus. We tested the hypothesis that circulating fatty acid biomarkers of dairy fat, 15:0, 17:0, and t-16:1n-7, are associated with lower incident diabetes mellitus. METHODS AND RESULTS: Among 3333 adults aged 30 to 75 years and free of prevalent diabetes mellitus at baseline, total plasma and erythrocyte fatty acids were measured in blood collected in 1989 to 1990 (Nurses' Health Study) and 1993 to 1994 (Health Professionals Follow-Up Study). Incident diabetes mellitus through 2010 was confirmed by a validated supplementary questionnaire based on symptoms, diagnostic tests, and medications. Risk was assessed by using Cox proportional hazards, with cohort findings combined by meta-analysis. During mean±standard deviation follow-up of 15.2±5.6 years, 277 new cases of diabetes mellitus were diagnosed. In pooled multivariate analyses adjusting for demographics, metabolic risk factors, lifestyle, diet, and other circulating fatty acids, individuals with higher plasma 15:0 had a 44% lower risk of diabetes mellitus (quartiles 4 versus 1, hazard ratio, 0.56; 95% confidence interval, 0.37-0.86; P-trend=0.01); higher plasma 17:0, 43% lower risk (hazard ratio, 0.57; 95% confidence interval, 0.39-0.83; P-trend=0.01); and higher t-16:1n-7, 52% lower risk (hazard ratio, 0.48; 95% confidence interval, 0.33-0.70; P-trend <0.001). Findings were similar for erythrocyte 15:0, 17:0, and t-16:1n-7, although with broader confidence intervals that only achieved statistical significance for 17:0. CONCLUSIONS: In 2 prospective cohorts, higher plasma dairy fatty acid concentrations were associated with lower incident diabetes mellitus. Results were similar for erythrocyte 17:0. Our findings highlight the need to better understand the potential health effects of dairy fat, and the dietary and metabolic determinants of these fatty acids.
BACKGROUND: In prospective studies, the relationship of self-reported consumption of dairy foods with risk of diabetes mellitus is inconsistent. Few studies have assessed dairy fat, using circulating biomarkers, and incident diabetes mellitus. We tested the hypothesis that circulating fatty acid biomarkers of dairy fat, 15:0, 17:0, and t-16:1n-7, are associated with lower incident diabetes mellitus. METHODS AND RESULTS: Among 3333 adults aged 30 to 75 years and free of prevalent diabetes mellitus at baseline, total plasma and erythrocyte fatty acids were measured in blood collected in 1989 to 1990 (Nurses' Health Study) and 1993 to 1994 (Health Professionals Follow-Up Study). Incident diabetes mellitus through 2010 was confirmed by a validated supplementary questionnaire based on symptoms, diagnostic tests, and medications. Risk was assessed by using Cox proportional hazards, with cohort findings combined by meta-analysis. During mean±standard deviation follow-up of 15.2±5.6 years, 277 new cases of diabetes mellitus were diagnosed. In pooled multivariate analyses adjusting for demographics, metabolic risk factors, lifestyle, diet, and other circulating fatty acids, individuals with higher plasma 15:0 had a 44% lower risk of diabetes mellitus (quartiles 4 versus 1, hazard ratio, 0.56; 95% confidence interval, 0.37-0.86; P-trend=0.01); higher plasma 17:0, 43% lower risk (hazard ratio, 0.57; 95% confidence interval, 0.39-0.83; P-trend=0.01); and higher t-16:1n-7, 52% lower risk (hazard ratio, 0.48; 95% confidence interval, 0.33-0.70; P-trend <0.001). Findings were similar for erythrocyte 15:0, 17:0, and t-16:1n-7, although with broader confidence intervals that only achieved statistical significance for 17:0. CONCLUSIONS: In 2 prospective cohorts, higher plasma dairy fatty acid concentrations were associated with lower incident diabetes mellitus. Results were similar for erythrocyte 17:0. Our findings highlight the need to better understand the potential health effects of dairy fat, and the dietary and metabolic determinants of these fatty acids.
Authors: Jason H Y Wu; Rozenn N Lemaitre; Fumiaki Imamura; Irena B King; Xiaoling Song; Donna Spiegelman; David S Siscovick; Dariush Mozaffarian Journal: Am J Clin Nutr Date: 2011-06-22 Impact factor: 7.045
Authors: Mohammad Y Yakoob; Peilin Shi; Frank B Hu; Hannia Campos; Kathryn M Rexrode; E John Orav; Walter C Willett; Dariush Mozaffarian Journal: Am J Clin Nutr Date: 2014-09-24 Impact factor: 7.045
Authors: Sabita S Soedamah-Muthu; Eric L Ding; Wael K Al-Delaimy; Frank B Hu; Marielle F Engberink; Walter C Willett; Johanna M Geleijnse Journal: Am J Clin Nutr Date: 2010-11-10 Impact factor: 7.045
Authors: Mu Chen; Qi Sun; Edward Giovannucci; Dariush Mozaffarian; JoAnn E Manson; Walter C Willett; Frank B Hu Journal: BMC Med Date: 2014-11-25 Impact factor: 8.775
Authors: Nita G Forouhi; Albert Koulman; Stephen J Sharp; Fumiaki Imamura; Janine Kröger; Matthias B Schulze; Francesca L Crowe; José María Huerta; Marcela Guevara; Joline W J Beulens; Geertruida J van Woudenbergh; Laura Wang; Keith Summerhill; Julian L Griffin; Edith J M Feskens; Pilar Amiano; Heiner Boeing; Françoise Clavel-Chapelon; Laureen Dartois; Guy Fagherazzi; Paul W Franks; Carlos Gonzalez; Marianne Uhre Jakobsen; Rudolf Kaaks; Timothy J Key; Kay-Tee Khaw; Tilman Kühn; Amalia Mattiello; Peter M Nilsson; Kim Overvad; Valeria Pala; Domenico Palli; J Ramón Quirós; Olov Rolandsson; Nina Roswall; Carlotta Sacerdote; María-José Sánchez; Nadia Slimani; Annemieke M W Spijkerman; Anne Tjonneland; Maria-José Tormo; Rosario Tumino; Daphne L van der A; Yvonne T van der Schouw; Claudia Langenberg; Elio Riboli; Nicholas J Wareham Journal: Lancet Diabetes Endocrinol Date: 2014-08-05 Impact factor: 32.069
Authors: Joshua J Joseph; Justin B Echouffo-Tcheugui; Mercedes R Carnethon; Alain G Bertoni; Christina M Shay; Haitham M Ahmed; Roger S Blumenthal; Mary Cushman; Sherita H Golden Journal: Diabetologia Date: 2016-06-08 Impact factor: 10.122
Authors: Fabiola M Del Razo Olvera; Marco A Melgarejo Hernández; Roopa Mehta; Carlos A Aguilar Salinas Journal: Adv Nutr Date: 2017-01-17 Impact factor: 8.701
Authors: Kim Kummer; Paul N Jensen; Mario Kratz; Rozenn N Lemaitre; Barbara V Howard; Shelley A Cole; Amanda M Fretts Journal: J Nutr Date: 2019-07-01 Impact factor: 4.798
Authors: Eduardo Villamor; Luis A Villar; Anyela Lozano-Parra; Víctor M Herrera; Oscar F Herrán Journal: Br J Nutr Date: 2018-08-14 Impact factor: 3.718
Authors: Mary Catherine Sawh; Martina Wallace; Emma Shapiro; Nidhi P Goyal; Kimberly P Newton; Elizabeth L Yu; Craig Bross; Janis Durelle; Cynthia Knott; Jon A Gangoiti; Bruce A Barshop; Jivani M Gengatharan; Noah Meurs; Alexandra Schlein; Michael S Middleton; Claude B Sirlin; Christian M Metallo; Jeffrey B Schwimmer Journal: J Pediatr Gastroenterol Nutr Date: 2021-04-01 Impact factor: 2.839